Trial intelligence / Profile preview

Dopaminergic System and Mobility Resilience in Older Adults

NCT06587217Phase 2Completed

Sponsor
University of Michigan
Start
Oct 2024
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of carbidopa + levodopa, sponsored by University of Michigan. Started Oct 2024; status: completed.

02

Drugs

carbidopa + levodopa

Beyond the preview

Go deeper on NCT06587217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06587217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call